Supernus Pharmaceuticals, Inc. (SUPN)
50.54
+0.06
(+0.12%)
USD |
NASDAQ |
Apr 06, 16:00
50.59
+0.05
(+0.10%)
After-Hours: 20:00
Supernus Pharmaceuticals Market Cap : 2.917B for April 6, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Biogen, Inc. | 24.57B |
| BridgeBio Pharma, Inc. | 13.85B |
| Corcept Therapeutics, Inc. | 4.178B |
| Catalyst Pharmaceuticals, Inc. | 3.087B |
| Cytokinetics, Inc. | 7.787B |
Market Cap Related Metrics
| PS Ratio | 3.988 |
| Price to Book Value | 2.747 |
| Price to Free Cash Flow | 62.33 |
| Price | 50.54 |
| Earnings Yield | -1.35% |